The Valley Desk

NCT01919801 · Interventional trial

Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Overall registry status Completed

Phase 3

Conditions Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov